Shares of Pain Therapeutics (PTIE +1.4%) benefit from the FDA's "public health priority" call on...

|About: Pain Therapeutics (PTIE)|By:, SA News Editor

Shares of Pain Therapeutics (PTIE +1.4%) benefit from the FDA's "public health priority" call on abuse-deterrent opioid analgesics. PTIE is developing Remoxy, an abuse-resistant form of oxycodone in conjunction with Pfizer (PFE). Other names moving on the news: ACUR +70% and ENDP +3.2%.